Trademark Search > Trademark Owners > N > Novartis AG

Novartis AG Trademarks (4661 records)

Trademarkia.com is a free search engine of publicly available government records. Trademarkia.com is not a law firm and does not represent owners listed on this page.

Company Trademark Status Update Alerts are email updates of the latest trademarks' status change on company level. Click here to get the alert for FREE!

Page 1 of 234

Goods and Services: Pharmaceutical preparations for the prevention or treatment of diseases and disorders of the ...
LIVE (Circa: 2018)

KINVITAR

Goods and Services: Surgical apparatus and instruments for use in ophthalmic surgery, namely, vitreoretinal surgery
LIVE (Circa: 2018)

UNIFEYE

Goods and Services: Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal ...
LIVE (Circa: 2018)

WAYZENT

Goods and Services: Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal ...
LIVE (Circa: 2018)

EMZENT

Goods and Services: Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal ...
LIVE (Circa: 2018)

MAEZENT

Goods and Services: Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal ...
LIVE (Circa: 2018)

MEYZENT

Goods and Services: Contact lenses
LIVE (Circa: 2018)

AQUACOMFORT PLATINUM

Goods and Services: Educational services, namely, providing seminars in the field of ophthalmology, and distribut...
LIVE (Circa: 2018)

STREAMLIGHT

Goods and Services: Downloadable mobile applications for converting text and images to audio, to assist the visua...
LIVE (Circa: 2017)

FOCAL VIEW

Goods and Services: Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal ...
LIVE (Circa: 2017)

RIMADY

Goods and Services: Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal ...
LIVE (Circa: 2017)

XAMOXA

Goods and Services: Providing medical information to healthcare professionals in the field of surgical ophthalmology
LIVE (Circa: 2017)

SERVICE PERFORMAX

Goods and Services: (Based on Intent to Use) Pharmaceutical preparations for the treatment and prevention of dise...
LIVE (Circa: 2017)

AIRTIYO

Goods and Services: Surgical apparatus for use in ophthalmic surgery
LIVE (Circa: 2017)

UNIPURE

Goods and Services: (Based on Intent to Use) Surgical apparatus and instruments for use in ophthalmic surgery(Bas...
LIVE (Circa: 2017)

FINESSE REFLEX

Goods and Services: Educational services, namely, conducting training programs in the field of eye care
LIVE (Circa: 2017)

ACADEMY FOR EYECARE EXCELLENCE

Goods and Services: Contact lenses
LIVE (Circa: 2017)

DIGIVISION

Goods and Services: Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal ...
LIVE (Circa: 2017)

YMAGUS

Goods and Services: Educational services, namely, training services for professionals in the field of ophthalmology
LIVE (Circa: 2017)

ACTIVATE

Goods and Services: Ophthalmic preparations
LIVE (Circa: 2017)

SYSTANE BALANCE

Hot News! On Friday, January 5, 2018, a U.S. federal trademark registration number 87744777 was filed for STREAMLIGHT by Novartis AG with the description Educational services, namely, providing seminars in the field of ophthalmology, and distributing course materials in connection therewith.

Hot News! On Monday, January 8, 2018, a U.S. federal trademark registration number 87746776 was filed for WAYZENT by Novartis AG with the description Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma.

Hot News! On Monday, January 8, 2018, a U.S. federal trademark registration number 87746779 was filed for EMZENT by Novartis AG with the description Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma.

Hot News! On Monday, January 8, 2018, a U.S. federal trademark registration number 87746788 was filed for MAEZENT by Novartis AG with the description Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma.

Hot News! On Monday, January 8, 2018, a U.S. federal trademark registration number 87746790 was filed for MEYZENT by Novartis AG with the description Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma.

Hot News! On Monday, January 8, 2018, a U.S. federal trademark registration number 87747134 was filed for AQUACOMFORT PLATINUM by Novartis AG with the description Contact lenses.

Hot News! On Wednesday, January 10, 2018, a U.S. federal trademark registration number 87749637 was filed for UNIFEYE by Novartis AG with the description Surgical apparatus and instruments for use in ophthalmic surgery, namely, vitreoretinal surgery.

Hot News! On Friday, January 12, 2018, a U.S. federal trademark registration number 87752981 was filed for KINVITAR by Novartis AG with the description Pharmaceutical preparations for the prevention or treatment of diseases and disorders of the central nervous system, the immune system, the metabolic system and the musculo-skeletal system; pharmaceutical preparations for the treatment of inflammatory disorders and pain; pharmaceutical products for the prevention and treatment of hormonal deficiency and metabolic disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders.

Abandonment Notice! On Saturday, December 30, 2017, a U.S. federal trademark for Novartis AG registration number 79193116 was abandoned having the name WOMEN TALK COPD. The Reason provided as ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE. Apply Now for this name, Starts at $199!

Abandonment Notice! On Thursday, January 4, 2018, a U.S. federal trademark for Novartis AG registration number 79193861 was abandoned having the name WOMEN TALK COPD. The Reason provided as ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE. Apply Now for this name, Starts at $199!

Abandonment Notice! On Friday, January 12, 2018, a U.S. federal trademark for Novartis AG registration number 85120937 was abandoned having the name MORE MOISTURE BY DESIGN. The Reason provided as CONTINUED USE NOT FILED WITHIN GRACE PERIOD, UN-REVIVABLE. Apply Now for this name, Starts at $199!

Abandonment Notice! On Friday, December 29, 2017, a U.S. federal trademark for Novartis AG registration number 85166857 was abandoned having the name GALVUS. The Reason provided as CONTINUED USE NOT FILED WITHIN GRACE PERIOD, UN-REVIVABLE. Apply Now for this name, Starts at $199!

Abandonment Notice! On Tuesday, January 16, 2018, a U.S. federal trademark for Novartis AG registration number 85308324 was abandoned having the name ECLIPSE. The Reason provided as VOLUNTARY SURRENDER OF REGISTRATION. Apply Now for this name, Starts at $199!

Abandonment Notice! On Monday, December 25, 2017, a U.S. federal trademark for Novartis AG registration number 86237147 was abandoned having the name FLASH. The Reason provided as ABANDONED - NO STATEMENT OF USE FILED. Apply Now for this name, Starts at $199!

Abandonment Notice! On Monday, December 25, 2017, a U.S. federal trademark for Novartis AG registration number 86329887 was abandoned having the name RYVERNA. The Reason provided as ABANDONED - NO STATEMENT OF USE FILED. Apply Now for this name, Starts at $199!

Abandonment Notice! On Monday, December 25, 2017, a U.S. federal trademark for Novartis AG registration number 86340054 was abandoned having the name AEROCOMP. The Reason provided as ABANDONED - NO STATEMENT OF USE FILED. Apply Now for this name, Starts at $199!

Abandonment Notice! On Monday, December 25, 2017, a U.S. federal trademark for Novartis AG registration number 86340070 was abandoned having the name . The Reason provided as ABANDONED - NO STATEMENT OF USE FILED. Apply Now for this name, Starts at $199!

Abandonment Notice! On Monday, January 15, 2018, a U.S. federal trademark for Novartis AG registration number 86792843 was abandoned having the name QIZERZ. The Reason provided as ABANDONED - NO STATEMENT OF USE FILED. Apply Now for this name, Starts at $199!